![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, October 19, 2020 6:05:09 PM
We both agree on everything except whether it moves directly into Phase3. It's a matter of semantics, in my opinion.
While there will be delay to the start, based off Phase2 data of which will be calculated into Phase3 enrollment, it's only to assess the data from Phase2.
There will be no "application/approval process". It is already authorized.
As he states at 18:30, it's a Phase 2b/3 study.
As for the Summer of '21 projection..
I will be (nearly) long gone by then.
This has always been an, as you stated, "Option 3" best-case scenario for investor's.
I've been invested for nearly 4yrs. After contemplating total sell-off after the reverse-split, I became interested in the "repurposed drugs" idea (thanks to the great DD offered here by the Band..lol).
COVID-19 came and the connection to what the company was already investigating, and, it should be noted again.. unlike most pursuing a treatment/therapeutic, COVID-19 came to Algernon.
So I increased my position.
I will always stick around with a few tickets to see where my original investment goes with IPF/Chronic Cough.. and the other 3 in the pipeline. But the COVID-19 angle is coming to a Day of Reckoning, and soon.
Good luck Algernaut's... commencing Countdown.
LS5
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM